# Cervical Cancer Screening Based on First-void Urine Self-sampling to Reach un(Der)-Screened Women: ScreenUrSelf Trial

> **NCT05996783** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Universiteit Antwerpen** · enrollment: 48000 (estimated)

## Conditions studied

- Cervix Cancer
- Cervical Intraepithelial Neoplasia
- Human Papilloma Virus
- HPV-Related Cervical Carcinoma

## Interventions

- **DEVICE:** Colli-Pee Small Volumes
- **DEVICE:** Evalyn Brush

## Key facts

- **NCT ID:** NCT05996783
- **Lead sponsor:** Universiteit Antwerpen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-05-25
- **Primary completion:** 2024-03-31
- **Final completion:** 2026-09-30
- **Target enrollment:** 48000 (ESTIMATED)
- **Last updated:** 2025-06-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05996783

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05996783, "Cervical Cancer Screening Based on First-void Urine Self-sampling to Reach un(Der)-Screened Women: ScreenUrSelf Trial". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05996783. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*